Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Ubiquitin-Specific Protease 52 as a Prognostic Biomarker Correlates with Tumor Microenvironment and Therapy Response in Colorectal Cancer.

Oncology - 1 Jan 2024

Zhou Jingkai, Nie Haihang, Yang Xiaoqiang, Wang Fan, Yu Panpan, Yu Yali, Ning Yumei, Lai Jun, Wang Haizhou, Zhao Qiu, Xu Fei

Abstract excerpt

INTRODUCTION: As the primary members of the deubiquitinase family, ubiquitin-specific proteases can regulate the efficacy of immunotherapy and mediate immune evasion. However, further research is needed to explore the influence of USP52 on the prognosis of colorectal cancer (CRC), the tumor immune microenvironment, and therapeutic response. METHODS: The differential expression of USP52 between CRC and normal...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers, Tumor
Share to Colorectal Neoplasms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Gene Expression Regulation, Neoplastic

Share to Immunotherapy

Share to Microsatellite Instability

Share to Prognosis

Share to Tumor Microenvironment

Share to Ubiquitin-Specific Proteases

Source

Identifiers

PMID: 39047691
DOI: 10.1159/000540441

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Ubiquitin-Specific Protease 52 as a Prognostic Biomarker Correlates with Tumor Microenvironment and Therapy Response in Colorectal Cancer.PMID 39047691Read ↗

Ubiquitin-specific peptidase 10, a deubiquitinating enzyme: Assessing its role in tumor prognosis and immune responseSemantic proximity Read ↗

Integrative and Comprehensive Pan-cancer Analysis of Ubiquitin Specific Peptidase 11 (USP11) As a Prognostic and Immunological BiomarkerSemantic proximity Read ↗

USP18 Is Associated with PD-L1 Antitumor Immunity and Improved Prognosis in Colorectal CancerSemantic proximity Read ↗

System-wide identification of novel de-ubiquitination targets for USP10 in gastric cancer metastasis through multi-omics screeningSemantic proximity Read ↗

Gene Signature and Prognostic Value of Ubiquitin-Specific Proteases Members in Hepatocellular Carcinoma and Explored the Immunological Role of USP36Semantic proximity Read ↗

c-MYC-USP49-BAG2 axis promotes proliferation and chemoresistance of colorectal cancer cells in vitroSemantic proximity Read ↗

A pan-cancer analysis of USP5: its diagnostic, prognostic and immunological roles in human cancersSemantic proximity Read ↗

The emerging role of ubiquitin-specific protease 20 in tumorigenesis and cancer therapeuticsSemantic proximity Read ↗

A pan-cancer analysis of the role of USP5 in human cancersSemantic proximity Read ↗

USP14 promotes colorectal cancer progression by targeting JNK for stabilizationSemantic proximity Read ↗

Transcriptome Analysis and Single-Cell Sequencing Analysis Constructed the Ubiquitination-Related Signature in Glioma and Identified USP4 as a Novel BiomarkerSemantic proximity Read ↗

USP35 promotes cell proliferation and chemotherapeutic resistance through stabilizing FUCA1 in colorectal cancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.